← Back to Search

Opioid Analgesic

hemodialysis for Chronic Kidney Disease (OCKD Trial)

Phase 4
Waitlist Available
Led By Oscar A Linares, MD
Research Sponsored by Emerio & Lourdes Linares Research and Education Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up t=0 to t=4 hours
Awards & highlights

OCKD Trial Summary

To measure oxycodone's intradialytic mass transfer rate coefficient and oxycodone's removal rate using an ODE/PDE hemodialysis model. To implement a rational clinical strategy for estimating a patient's post-hemodialysis oxycodone restoration dose using results from an ODE/PDE model of hemodialysis.

Eligible Conditions
  • Chronic Kidney Disease

OCKD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~t=0 to t=4 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and t=0 to t=4 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Oxycodone's intradialytic mass transfer coefficient

Side effects data

From 2022 Phase 4 trial • 393 Patients • NCT04122443
8%
Drowsiness
3%
Dizziness
100%
80%
60%
40%
20%
0%
Study treatment Arm
Ibuprofen and Then Acetaminophen (Stage 2)
Ibuprofen and Then Oxycodone/Acetaminophen (Stage 2)
Ibuprofen (Stage 1)

OCKD Trial Design

2Treatment groups
Experimental Treatment
Group I: hemodialysisExperimental Treatment1 Intervention
Oxycodone will be administered and subjects will undergo hemodialysis
Group II: controlExperimental Treatment1 Intervention
Oxycodone will be administered and subjects will undergo hemodialysis
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Oxycodone
FDA approved

Find a Location

Who is running the clinical trial?

Emerio & Lourdes Linares Research and Education CenterLead Sponsor
Oscar A Linares, MDPrincipal InvestigatorEmerio & Lourdes Linares Research and Education Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Opioids in Chronic Kidney Disease Patients Undergoing Hemodialysis
2015. "Opioids in Chronic Kidney Disease Patients Undergoing Hemodialysis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02452437.
All > Chronic Kidney Disease
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top